• February’s top news stories

    Top executives from seven major pharmaceutical companies have appeared before the US Finance Committee to testify about the high prices of prescription drugs in the country, and GE has agreed...

  • Developing a new class of cancer combo drugs

    Cybrexa, a spin-out company from Yale University, is developing a new class of cancer therapeutics, looking to identify combinations of chemotherapy and DNA inhibitors to increase efficacy and reduce toxicity...

  • November’s top stories

    Sobi has signed agreements to acquire the rights to AstraZeneca’s Synagis medicine in the US for an upfront payment of $1.5bn, and Takeda Pharmaceutical has received a conditional approval from...

Go Top